OPKO Health, Inc. announced it will release its financial results for the three and 12 months ending December 31, 2024, on February 27, 2025, after U.S. market close. A conference call and audio ...

OPKO Health will present at the J.P. Morgan Healthcare Conference and host investor meetings from January 13-16, 2025. OPKO Health, Inc. announced that its management will participate in the 43rd ...

We recently compiled a list of the 10 Best Stocks Under $3 to Buy Now. In this article, we are going to take a look at where OPKO Health, Inc. (NASDAQ:OPK) stands against the other stocks under $3.

Opko Health Inc. (NASDAQ:OPK) is one of the best stocks under $5 with highest upside potential. ModeX Therapeutics Inc., an Opko Health Inc. (NASDAQ:OPK) company, announced on October 29 a license and ...

Good day, and welcome to the OPKO Health Third Quarter of 2024 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, ...

OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, courtesy of its potential in RAYALDEE. The optimism surrounding the stock is backed by RAYALDEE’s performance and strategic ...

Opko announces it entered into a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx). The company also announces a $100 million share repurchase program. Historic Summer ...

MIAMI and JERUSALEM, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX) (“Entera”) today announced that new pharmacologic and pharmacokinetic in vivo ...

Market forces rained on the parade of OPKO Health, Inc. (NASDAQ:OPK) shareholders today, when the analysts downgraded their forecasts for next year. Revenue and earnings per share (EPS) forecasts were ...

Hello, and welcome to the OPKO Health First Quarter 2024 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions]. After today's presentation, there ...